Healthcare -
Biotechnology - NASDAQ - US
$ 3.76
-0.529 %
$ 336 M
Market Cap
-8.55
P/E
TRVI - NET CHANGE IN CASH
Net Change in Cash TRVI - Trevi Therapeutics, Inc.
19.8 M
LAST VALUE
110.34%
2 YEAR CAGR
27.25%
5 YEAR CAGR
0.00%
10 YEAR CAGR